rs113993980
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_002863.5(PYGL):c.1471C>T(p.Arg491Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,613,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R491H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_002863.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PYGL | NM_002863.5 | c.1471C>T | p.Arg491Cys | missense_variant | 12/20 | ENST00000216392.8 | NP_002854.3 | |
PYGL | NM_001163940.2 | c.1369C>T | p.Arg457Cys | missense_variant | 11/19 | NP_001157412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYGL | ENST00000216392.8 | c.1471C>T | p.Arg491Cys | missense_variant | 12/20 | 1 | NM_002863.5 | ENSP00000216392.7 | ||
PYGL | ENST00000532462.5 | c.1471C>T | p.Arg491Cys | missense_variant | 12/20 | 1 | ENSP00000431657.1 | |||
PYGL | ENST00000544180.6 | c.1369C>T | p.Arg457Cys | missense_variant | 11/19 | 2 | ENSP00000443787.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251460Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135904
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461766Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727202
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
Glycogen storage disease, type VI Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2022 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg491 amino acid residue in PYGL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 33763395). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PYGL protein function. ClinVar contains an entry for this variant (Variation ID: 21329). This missense change has been observed in individuals with clinical features of glycogen storage disease (PMID: 17705025; Invitae). This variant is present in population databases (rs113993980, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 491 of the PYGL protein (p.Arg491Cys). - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at